Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 872 across all filing types
Latest filing 2025-07-11 Interim / Quarterly Rep…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM REPORT 1 JANUARY – 30 JUNE 2025' and contains comprehensive financial statements, including income statements, cash flow analysis, and management commentary for the six-month period. It provides detailed financial data rather than just an announcement or certification, fitting the definition of an Interim/Quarterly Report. H1 2025
2025-07-11 English
Notice of Extraordinary General Meeting of Episurf Medical AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of Extraordinary General Meeting of Episurf Medical AB (publ)". It details the date, time, location, and procedures for shareholders to exercise their voting rights, including physical attendance and postal voting instructions. The agenda proposes resolutions concerning amendments to the articles of association and a rights issue. This content is characteristic of a formal notice sent to shareholders to convene a meeting where important corporate decisions are voted upon. This aligns perfectly with the definition of materials shared for a General Meeting, which is best categorized as AGM-R (AGM Information), even though it is an Extraordinary General Meeting (EGM) notice, as AGM-R is the closest fit for general meeting materials among the provided codes. It is not a proxy statement (PSI) as it is the notice itself, nor is it a DVA (Declaration of Voting Results) as it precedes the vote.
2025-07-03 English
Kallelse till extra bolagsstämma i Episurf Medical AB (publ)
AGM Information Classification · 1% confidence The document is titled "Kallelse till extra bolagsstämma i Episurf Medical AB (publ)" which translates to "Notice of Extraordinary General Meeting in Episurf Medical AB (publ)". It details the date, time, location, procedures for participation (physical attendance or postal voting), and the proposed agenda items, which include changes to the articles of association and a rights issue proposal. This content is characteristic of a formal notice sent to shareholders to convene a meeting where voting will take place. The closest matching category is related to shareholder meetings and voting information. While it is a notice, it is specifically for an Extraordinary General Meeting (EGM), and the core purpose is to solicit shareholder participation and voting on specific proposals. This aligns best with the concept of a notice for a general meeting, which often overlaps with Proxy Solicitation/Information Statements (PSI) or general AGM materials (AGM-R). Since it is an *Extra* General Meeting (EGM) notice detailing voting procedures and proposals, it functions as a primary document for shareholder decision-making, similar to a proxy statement or the notice itself. Given the options, 'AGM-R' (AGM Information) is the most appropriate fit for a general meeting notice, even if it's an EGM, as it contains the core information needed for the meeting. It is not a DEF 14A (Remuneration) or DVA (Voting Results), but the notice itself.
2025-07-03 Swedish
Episurf Medical announces a rights issue of units of up to approximately SEK 29.4 million
Share Issue/Capital Change Classification · 1% confidence The document explicitly announces a 'rights issue of units of up to approximately SEK 29.4 million'. A rights issue is a specific type of corporate action related to raising capital through the issuance of new shares/units to existing shareholders with preferential rights. This directly aligns with the definition of 'Capital/Financing Update' (CAP). The document details the structure (shares and warrants), subscription price, dilution, and intended use of proceeds, confirming it is the primary announcement of a financing event, not just a general regulatory filing or a report announcement.
2025-07-02 English
Episurf Medical offentliggör en företrädesemission av units om högst cirka 29,4 MSEK
Capital/Financing Update Classification · 1% confidence The document is a press release announcing a rights issue ('företrädesemission') of units to raise capital (approximately 29.4 MSEK). It details the structure of the offering (shares and warrants), subscription price, use of proceeds (FDA process, sales support), and the requirement for approval at an Extraordinary General Meeting (Extra Bolagsstämman). This clearly falls under the category of corporate financing activities, specifically related to raising capital through issuing new securities (shares/units). This matches the definition for 'Capital/Financing Update' (CAP). Although a prospectus will be published later (which might trigger an RPA), the core content here is the announcement and details of the capital raise itself.
2025-07-02 Swedish
Episurf Medical annonserar omstruktureringsinitiativ och ökat fokus på den amerikanska marknaden
Earnings Release Classification · 1% confidence The document is a press release from Episurf Medical announcing a restructuring initiative to reduce operating costs and increase focus on the US market. It details cost-saving measures, changes in the European sales organization (moving to distributors), and progress in US commercialization (510(k) process). The final paragraph explicitly states: "Denna information är sådan information som Episurf Medical AB är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning." (This information is information that Episurf Medical AB is obliged to disclose pursuant to the EU's Market Abuse Regulation). This indicates a mandatory regulatory disclosure regarding significant internal operational changes that impact the company's structure and outlook. Since it is not a formal financial report (10-K, IR, ER), nor a specific announcement like a dividend (DIV) or director dealing (DIRS), it best fits the general category for mandatory regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS). Given the content is a strategic operational update rather than a financial result release, RNS is the most appropriate classification. Q2 2025
2025-07-02 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.